Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04756401 |
| Title | Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Academic and Community Cancer Research United |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | United States | Details | |
| State University of New York Upstate Medical University | Syracuse | New York | 13210 | United States | Details | |
| UNC Lineberger Comprehensive Cancer Center University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | United States | Details | |
| Carolinas Medical Center/Levine Cancer Institute | Charlotte | North Carolina | 28203 | United States | Details |